• We are developing growth hormone injection as a microneedle patch to provide a new option for children who need growth hormone administration.

• Through the development of growth hormone microneedle applied with Daewoong Therapeutics' CPM microneedle technology, room temperature stability of biopharmaceuticals and efficacy equality with injections were confirmed.

hGH content in MN

hGH Impurity in MN

Using biopharmaceutical somatropin (growth hormone) as a model drug, securing stability under room temperature/refrigeration conditions for 6 months

• We are developing to provide a new option to replace injection/oral medications by using GLP-1 drug, a game changer in diabetes/obesity treatment.

• We are currently securing stability for distribution at room temperature, and we have secured the highest level of non-clinical test data.

Target dosage: 2.4 and 1 mg/patch (obesity/diabetes)
Number of microneedle: 100 ea
Microneedle area: 2x2 cm²
Estimated dosage: once a week transdermal administration

• We are developing to provide a new option to replace injections using botulinum toxin.

• Currently, we have secured the stability for distribution at room temperature and secured the highest level of non-clinical test data.

• It is expected to increase accessibility by reducing pain and improving the convenience of the procedure.

• It is expected to be used not only in the beauty field but also for various indications such as hyperhidrosis of the hands.



Number of microneedle: 9~16 ea
Area of microneedle: 0.5x0.5 cm²

• It is being developed to provide a new option to replace existing injections using a bone formation promoter drug used for osteoporosis patients.

• Currently, we have secured the stability for distribution at room temperature and secured the highest level of non-clinical test data.



Number of microneedles: 100 ea
Area of microneedle: 2x2 cm²
Estimated dosage: percutaneous administration once a week